Archive - May 2018
Daily Brief: Italy in turmoil, Pharma attacks Europe’s generics move and more
US approves UCB’s Cimzia for psoriasis
AB Sciences decides against re-examination of masitinib filing
Safety scuppers combo trials with J&J/Genmab’s Darzalex
Janssen terminates Darzalex/Tecentriq combo trial
Health and pharma link to tackle dementia in Greater Manchester
FDA gives priority review to Loxo-Bayer cancer treatment
J&J halts cancer combo trial
